What is he best known for?
The fields of study he is best known for:
Peter Bell mainly focuses on Virology, Transduction, Genetic enhancement, Virus and Transgene.
The concepts of his Virology study are interwoven with issues in Vector, Nucleic acid, Gene expression and Immunology.
His work deals with themes such as Gene delivery, Adeno-associated virus, Mutant and Capsid, which intersect with Transduction.
His Genetic enhancement research includes elements of Liver disease, Internal medicine and Endocrinology.
His work on Neutralizing antibody as part of general Virus research is often related to Germinal center, thus linking different fields of science.
His Transgene research incorporates elements of Retina, Immune system and Cell biology.
His most cited work include:
- A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice (315 citations)
- Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation (314 citations)
- Review: properties and assembly mechanisms of ND10, PML bodies, or PODs. (259 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Genetic enhancement, Virology, Immunology, Transgene and Virus.
His research in Genetic enhancement intersects with topics in Vector, Pharmacology, Molecular biology and Pathology.
His work carried out in the field of Virology brings together such families of science as Viral vector, Adeno-associated virus and Immunity.
His study focuses on the intersection of Immunology and fields such as Mucopolysaccharidosis type I with connections in the field of Iduronidase.
He interconnects Gene expression, T cell, Immune system, microRNA and Transduction in the investigation of issues within Transgene.
His research integrates issues of Genetic transfer and Antigen in his study of Virus.
He most often published in these fields:
- Genetic enhancement (44.83%)
- Virology (29.31%)
- Immunology (29.31%)
What were the highlights of his more recent work (between 2015-2021)?
- Genetic enhancement (44.83%)
- Transgene (28.45%)
- Adeno-associated virus (22.41%)
In recent papers he was focusing on the following fields of study:
Peter Bell mostly deals with Genetic enhancement, Transgene, Adeno-associated virus, Virus and Pharmacology.
He combines subjects such as Mutation, Vector, Cerebrospinal fluid and Molecular biology with his study of Genetic enhancement.
His Transgene study incorporates themes from Immune system, Immunology, Transduction and Cell biology.
His Immunology study combines topics from a wide range of disciplines, such as Lysosomal storage disease and Mucopolysaccharidosis type I.
His biological study spans a wide range of topics, including Iduronidase and Factor IX.
His Virus research includes themes of Toxicity, Immunosuppression, Vectors in gene therapy and Locus.
Between 2015 and 2021, his most popular works were:
- A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice (315 citations)
- Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN (215 citations)
- The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice. (141 citations)
In his most recent research, the most cited papers focused on:
Peter Bell mainly investigates Virus, Genetic enhancement, Immunology, Transgene and Adeno-associated virus.
His studies deal with areas such as Stem cell, Cell biology, Transduction and Locus as well as Virus.
Peter Bell has included themes like Virology, Spinal muscular atrophy, Acute toxicity, Capsid and Genetically modified mouse in his Transduction study.
Peter Bell works mostly in the field of Genetic enhancement, limiting it down to topics relating to Cisterna magna and, in certain cases, Mucopolysaccharidosis VII, as a part of the same area of interest.
His Transgene research is multidisciplinary, incorporating elements of Blood–brain barrier, Phenotype, LDL receptor, Vectors in gene therapy and Pharmacology.
His work carried out in the field of Adeno-associated virus brings together such families of science as Iduronidase, Motor neuron and Mucopolysaccharidosis type I.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
